|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current assets: | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Deferred offering costs associated with initial public offering | ||||||||
| Investments held in Trust Account | ||||||||
| Total Assets | ||||||||
| Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit: | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Accrued expenses | ||||||||
| Franchise tax payable | ||||||||
| Income taxes payable | ||||||||
| Convertible promissory note – related party | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting commissions | ||||||||
| Derivative warrant liabilities | ||||||||
| Total Liabilities | ||||||||
| Class A common stock, $0.0001 par value; 34,500,000 shares subject to possible redemption at $10.001 and $10.000 per share at June 30, 2022 and December 31, 2021, respectively | ||||||||
| Class A | ||||||||
| Total class A common stock, $0.0001 par value; 34,500,000 shares subject to possible redemption at $10.001 and $10.000 per share at June 30, 2022 and December 31, 2021, respectively | ||||||||
| Stockholders' Deficit: | ||||||||
| Common stock, value | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Total Stockholders' Deficit | ||||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit |
Loading...
